Juvenile xanthogranuloma, JXG, nevoxanthoendothelioma

Definition

A histiocytic disorder of childhood, grouped with Langerhans' cell granulomatosis as a "dendritic cell related" proliferation. These are contrasted with the "macrophage related proliferations" (papular xanthoma, benign cephalic histiocytosis, sinus histiocytosis with massive lymphadenopathy [Rosai-Dorfmann disease] and haemophagocytic syndromes). Spindle cell xanthogranuloma, progressive nodular histiocytosis, xanthoma disseminatum and generalized eruptive histiocytosis may all be variants of juvenile xanthogranuloma.

Epidemiology

This is predominantly a disorder of the first two decades of life, 45%2 to 75%3 of patients developing the lesions as infants, 95% by the age of 10 years3. There is a reported association with neurofibromatosis type I and juvenile myelomonocytic leukaemia2.

Clinical features

Skin is the most commonly involved site, with a predilection for the head and neck. Most cases involve a solitary skin lesion. About 8% of the cutaneous cases are multiple; these patients are predominantly male infants. There is seldom progression form solitary to multiple skin lesions. A few patients present with plaques.

A minority of patients show single or multi-organ disease, with or without skin involvement. There is a predilection for the head and neck and soft tissue tumours are most common in infants.

 

Solitary skin lesion

116/1742, 94/1293

 

subcutis/soft tissue

28/1742, 19/1293

multiple skin only

13/1742, 11/1293

solitary extracutaneous

9/1742, 2/1293

multiple skin and other systems

8/1742, 3/1293

 

Macroscopic appearances

Skin lesions most commonly present as yellow to red papules measuring less than 1 cm.

Histopathology

The lesions are fairly well demarcated but not encapsulated: there are often small projections into the surrounding tissue. Skin lesions usually consist of Touton giant cells and lipidised or non-lipidised mononuclear cells. In 20% of cases, there is a spindle cell component2. 10% of cases show some nuclear atypia and mitotic activity. There may be an infiltrate of eosinophils, lymphocytes and rarely plasma cells. There may be involvement of the papillary dermis and/or epidermis, with acanthosis (may be central flattening with peripheral acanthosis), parakeratosis, hypergranulosis or ulceration.

Three stages in the evolution of lesions have been described3:

 

 

Early JXG

Classic JXG

Late (transitional) JXG

Combined JXG

 

frequency

39/1443

68/1443

23/1443

14/1443

histiocytes

smallish, limited cytoplasm

abundant cytoplasm

storiform pattern of spindle cells resembling benign fibrous histiocytoma, plus foamy and giant cells

combination of these patterns within one lesion

 

lipid vacuoles

absent or fine

distinct vacuoles

 

nuclei

small, round to oval, may be indented

 

 

nucleoli

inconspicuous

 

 

Touton giant cells

usually absent

foreign body and early (lack cytoplasmic vacuolation) and typical Touton giant cells

 absent or rare

mitotic figures

some

 

 

eosinophils

scattered

 few

few

         
         

Soft tissue lesions are dominated by mononuclear cells and more commonly show mitotic activity.

Extracutaneous visceral lesions tend to be composed solely of mononuclear cells2. There is a variable spindle cell component. Enlarged hyperchromatic nuclei may be seen, but without mitoses.

Immunohistochemistry

 

CD68

28/282, 8/83

 

Factor XIIIa

28/282, 112/1133

vimentin

28/282

KI-M1P

121/1213

CD1a

0/282, 1/11, 0/1223

CD4

15/153

S-100

8/282, 7/1223

SMA

positivity only in late JXG3

   

Ultrastructure

Birbeck granules are never seen.

Differential diagnosis

Management

Prognosis

Solitary skin lesions recur after apparent complete excision in 7% of cases3. Spontaneous regression of multiple skin lesions has been inconsistently reported. Soft tissue lesions rarely recur, even when excision is incomplete. The systemic condition may prove fatal3. Infants may develop fatal giant cell hepatitis2.

References

1Andersen, W.K., Knowles, D.M. and Silvers, D.N. CD1 (OKT6)-positive juvenile xanthogranuloma. OKT6 is not specific for Langerhans cell histiocytosis (histiocytosis X). J Am Acad Dermatol 1992;26:850-4.

2Dehner, L.P. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 2003;27:579-93.

3Janssen, D. and D. Harms (2005). "Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry." Am J Surg Pathol 29(1): 21-8.

 

This page last revised 13.1.2005.

©SMUHT/PW Bishop